Open Access

Impact of kinetic isotope effects in isotopic studies of metabolic systems

BMC Systems Biology20159:64

https://doi.org/10.1186/s12918-015-0213-8

Received: 10 April 2015

Accepted: 19 September 2015

Published: 26 September 2015

Abstract

Background

Isotope labeling experiments (ILEs) are increasingly used to investigate the functioning of metabolic systems. Some enzymes are subject to kinetic isotope effects (KIEs) which modulate reaction rates depending on the isotopic composition of their substrate(s). KIEs may therefore affect both the propagation of isotopes through metabolic networks and their operation, and ultimately jeopardize the biological value of ILEs. However, the actual impact of KIEs on metabolism has never been investigated at the system level.

Results

First, we developed a framework which integrates KIEs into kinetic and isotopic models of metabolism, thereby accounting for their system-wide effects on metabolite concentrations, metabolic fluxes, and isotopic patterns. Then, we applied this framework to assess the impact of KIEs on the central carbon metabolism of Escherichia coli in the context of 13C-ILEs, under different situations commonly encountered in laboratories. Results showed that the impact of KIEs strongly depends on the label input and on the variable considered but is significantly lower than expected intuitively from measurements on isolated enzymes. The global robustness of both the metabolic operation and isotopic patterns largely emerge from intrinsic properties of metabolic networks, such as the distribution of control across the network and bidirectional isotope exchange.

Conclusions

These results demonstrate the necessity of investigating the impact of KIEs at the level of the entire system, contradict previous hypotheses that KIEs would have a strong effect on isotopic distributions and on flux determination, and strengthen the biological value of 13C-ILEs. The proposed modeling framework is generic and can be used to investigate the impact of all the isotopic tracers (2H, 13C, 15N, 18O, etc.) on different isotopic datasets and metabolic systems. By allowing the integration of isotopic and metabolomics data collected under stationary and/or non-stationary conditions, it may also assist interpretations of ILEs and facilitate the development of more accurate kinetic models with improved explicative and predictive capabilities.

Keywords

Isotope effect Isotope labeling experiment Metabolic flux analysis Fluxomics Kinetic model Isotopic model

Background

Isotopic studies are increasingly used to better understand the organization and the functioning of metabolic systems in systems biology and to assist the design of efficient and robust production strains in biotechnology [14]. The basic principle of isotope labeling experiments (ILEs) consists of: i) cultivating cells on an isotopically enriched substrate [5], ii) collecting metabolites using adequate sampling methods [68], and iii) quantifying their isotopic content by mass spectrometry (MS) and/or nuclear magnetic resonance (NMR) [912]. Isotopic data are typically exploited to identify metabolic pathways [13] and metabolites [14], to assist the discovery of new metabolite-protein regulatory interactions [15], to profile metabolic variants [16, 17], and to quantify metabolite and flux responses to environmental and genetic perturbations [18, 19].

The biological insights obtained from ILEs are valid provided isotopes do not modify the operation of the metabolic network investigated and no isotopic fractionation occurs in the network. However, many enzymes are subject to kinetic isotope effects (KIEs) that modify reaction rates depending on the isotopic composition of their substrate(s) [20]. For instance, it is well established that Rubisco, the carbon fixing enzyme of the Calvin cycle, assimilates preferentially 12CO2 over 13CO2 [21]. Therefore, KIEs modify the propagation of isotopes through the network and the isotopic data collected in ILEs. Since KIEs modify reaction rates, one can intuitively expect they also impact the operation of the metabolic systems investigated (i.e. metabolite concentrations and fluxes), and thus isotopic data themselves. However, the metabolic control may be distributed over different steps of a pathway, and in this case the change of rate constant of a particular reaction may not directly translate into a change of flux through the corresponding pathway. This systemic property of control distribution across the network was theoretically developed under the framework of metabolic control analysis [22, 23] and has been repeatedly observed in vivo [2427]. Changes of reaction rates may also propagate through the network and affect the metabolic operation and the distribution of isotopes in other parts of the network. Hence, KIEs may exert considerable effects over all variables of the system (metabolite concentrations, fluxes, and distribution of isotopes), and thus potentially jeopardize the biological value of ILEs. However, these effects are usually assumed to be negligible.

The first attempt to assess the impact of KIEs on the distribution of isotopes in intracellular metabolites was published recently, in the context of 13C-ILEs [28]. They concluded that in some situations the impact of KIEs of pyruvate dehydrogenase on the labeling of acetyl-CoA may be of comparable size to the measurement errors in GC-MS, hence introducing a significant bias in the estimated fluxes. In another study, Fan et al. [19] carried out 2H-ILEs to quantify the contribution of the pentose phosphate pathway to NADPH production in Escherichia coli. They corrected isotopic measurements for the strong isotopic fractionation related to 2H, assuming they have no impact on fluxes. Although highly informative, these studies were carried out at the level of a single metabolic node. Thus, they fail to account for the system-wide effect that these KIEs have over all metabolite concentrations, fluxes and isotopic distributions.

In this study, we first developed a modeling framework which combines isotopic and kinetic models, while taking the system-wide KIEs into account. This framework is based on the fluxomer concept [29], which represents the rates at which metabolic reactions transform each substrate(s) isotopomers. This allows for a straightforward integration of KIEs, which are measured for a particular (subset of) substrate(s) isotopomer(s). This generic framework was applied to investigate the impact of KIEs on the glycolytic and pentose phosphate pathways of the model bacterium E. coli, in the context of the most widely used 13C-ILEs. The impact of KIEs on metabolite concentrations, fluxes and isotopic distributions was quantified under a broad range of situations commonly encountered in laboratories (in terms of label input, metabolic state, and isotopic information considered).

Methods

Model construction

The kinetic model published by [30] was used as a scaffold to develop the isotopic system, as detailed in the results section, with carbon atom transitions taken from [6]. Since reversibility results in bidirectional isotope exchange [31], forward and backward rates of reversible reactions were considered separately by decomposing the rate laws into forward and backward components. For instance, in the case of the phosphoglycerate mutase (GPM) described by a reversible Michaelis-Menten-type rate law:
$$ {v}_{gpm}^{net}={V}_{max}\frac{PG3-\frac{PG2}{K_{eq}}}{K_m^{PG3}.\left(1+\frac{PG2}{K_m^{PG2}}\right)+PG3} $$
(1)
the forward (v forw ) and backward (v back ) rates are equal to:
$$ {v}_{gpm}^{forw}={V}_{max}\frac{PG3}{K_m^{PG3}.\left(1+\frac{PG2}{K_m^{PG2}}\right)+PG3} $$
(2)
$$ {v}_{gpm}^{back}={V}_{max}\frac{\frac{PG2}{K_{eq}}}{K_m^{PG3}.\left(1+\frac{PG2}{K_m^{PG2}}\right)+PG3} $$
(3)

The model thus contains 58 fluxes (32 irreversible and 13 reversible reactions) decomposed into 7376 fluxomers. This model describes the dynamics of 616 isotopomers (and 94 isotopologues) from 17 metabolites.

Five reactions included in the model are catalyzed by enzymes for which KIEs were identified (Table 1). However, KIEs were measured only for singly labeled isotopomers. KIEs related to multiply labeled isotopomers were approximated assuming effects are cumulative [28]. Multiply labeled isotopomers are therefore more strongly impacted by KIEs than singly labeled isotopomers.
Table 1

Kinetic isotope effects measured on five central metabolic enzymes. For multiply labeled isotopomers, α coefficients were approximated from KIEs of singly labeled isotopomers assuming KIEs are cumulative [28]; for instance, α PDH PYR_110  = α PDH PYR_100 . α PDH PYR_010

Enzyme

Reaction

Substrate

Isotopomer

α

Ref.

6-phosphogluconate dehydrogenase

GND

PGN

100000

0.9905

[48]

glucose-6-phosphate dehydrogenase

G6PDH

G6P

100000

0.9837

[49]

fructose-1,6-bisphosphate aldolase

ALD

FBP

001000

0.9843

[50]

ribulose-5-phosphate epimerase

RPE

RB5P

01000

0.9931

[51]

00100

0.9818

00010

0.9852

00001

0.9980

pyruvate dehydrogenase

PDH

PYR

100

0.9908

[52]

010

0.9791

001

0.9969

Simulations

The system of ordinary differential equations was automatically generated in FORTRAN, and steady-states were calculated using the LSODE solver implemented in the runsteady function of the rootSolve package (v1.6.5) of R (v3.0, www.r-project.org). Absolute and relative error tolerances were set to 10−8 and 10−6, respectively. All the scripts used to construct the models, perform the simulations and generate the figures are distributed in supplementary information (Additional file 1) under an open source license to ensure reproducibility and reusability.

Global sensitivity analysis

A global sensitivity analysis was carried out to evaluate the robustness of our conclusions under a broad range of metabolic states. To this end, steady-states were simulated for 10,000 sets of random enzyme levels generated using the runif function of R. For each set, maximum reaction rates (Vmax, which is proportional to the level of active enzyme) were sampled over two orders of magnitude (between 0.1 and 10 times the enzyme levels of the initial model) from a log uniform distribution to ensure each order of magnitude to be sampled in similar proportions.

Results and discussion

Modeling isotopic fractionation

A simple network is given in Fig. 1a as an example, with the corresponding carbon atom transitions shown in Fig. 1b. The labeling state of a metabolite containing n carbon atoms is denoted by the coefficients (a, b, …, n), which take a value of 0 if the atom in the corresponding carbon position is 12C or a value of 1 if the atom is 13C. For instance, B 0,1,1 represents the isotopomer of the metabolite B which is unlabeled in position 1 and labeled in positions 2 and 3. In the absence of KIEs, each isotopomer of a given metabolite reacts with a probability equal to its abundance relative to the total metabolite pool. Each isotopomer A a,b,c is thus produced at the rate v 1 weighted by \( {\overline{S}}_{a,b,c} \), which denotes the concentration of the isotopomer S a,b,c relative to the total S pool (\( {\displaystyle \sum_{a,b,c}}{S}_{a,b,c} \)). Similarly, A a,b,c is consumed at the rate v 2 weighted by Ā a,b,c , which denotes the concentration of the isotopomer A a,b,c relative to the total A pool. Therefore, the balance around the isotopomer A a,b,c is:
Fig. 1

A simple example network. a Representation of the example network in Systems Biology Graphical Notation format (SBGN, www.sbgn.org) [47]. Rounded rectangles represent enzymes, circles represent metabolites, and circles with dark bands along their bottoms represent metabolites which appear multiple times in the map. The concentration and labeling state of S are fixed, and reactions v 5–7 represent sink reactions. b Carbon transition network used to construct the isotopomers balances, where hexagons represent carbon positions. While v 1 and v 4 do not modify the carbon skeleton between substrates and products, other reactions result in carbon inversion (v 2) or in the reversible cleavage of carbon-carbon bonds (v 3)

$$ \frac{d{A}_{a,b,c}}{dt}={v}_1.{\overline{S}}_{a,b,c}-{v}_2.{\overline{A}}_{a,b,c} $$
(4)
where v 1 and v 2 are functions of the concentrations of reactants and effectors, and of the kinetic parameters of the enzymes catalyzing these reactions. This equation can be rewritten using the fluxomer variable introduced by [29]. A fluxomer is the rate at which a metabolic reaction transforms one or several substrate(s) isotopomers into product(s) isotopomers. Fluxomers are usually expressed as rate fractions [28, 29], which allows a direct mapping between fluxomers and isotopomer abundances. However, this is not relevant to calculate isotopomers derivatives. Therefore, fluxomers were expressed as absolute rates rather than rate fractions. In the absence of KIEs, the fluxomer f 1 a,b,c which consumes S a,b,c is defined by:
$$ {f}_1^{S_{a,b,c}}={v}_1.{\overline{S}}_{a,b,c} $$
(5)
and the mass balance around A a,b,c can be rewritten as:
$$ \frac{d{A}_{a,b,c}}{dt}={f}_1^{S_{a,b,c}}-{f}_2^{A_{a,b,c}} $$
(6)

It must be noted that the term "fluxomer" is somewhat misleading in the context of this study since it does not define a flux (which is a term used for the rate when the reaction is part of a whole system) but rather a local rate (i.e. the rate when considering the reaction isolated from the rest of the system). Bearing that in mind, we keep this terminology for sake of simplicity, but note the important distinction between these terms.

KIEs affect the rate constant of reactions depending on the isotopic composition of their substrate(s). Consequently, KIEs were included by weighting each fluxomer with a coefficient α which represents the KIE of a given enzyme with respect to its substrate(s) isotopomers. For instance, each coefficient \( {\alpha}_{v_2}^{A_{a,b,c}} \) is defined as:
$$ {\alpha}_{v_2}^{A_{a,b,c}}=\frac{v_2^{A_{a,b,c}}}{v_2^{A_{0,0,0}}} $$
(7)
where \( {v}_2^{A_{a,b,c}} \) (\( {v}_2^{A_{0,0,0}} \)) represents the rate of reaction 2 when isotopomer A a,b,c (A 0,0,0) is its unique substrate. The mass balance around A a,b,c finally becomes:
$$ \frac{d{A}_{a,b,c}}{dt}={\alpha}_{v_1}^{S_{a,b,c}}.{f}_1^{S_{a,b,c}}-{\alpha}_{v_2}^{A_{a,b,c}}.{f}_2^{A_{a,b,c}} $$
(8)
To calculate the mass balances for the isotopomers of pool B, two additional points must be taken into account. First, it is worth recalling that bidirectional isotope exchange that arise from reversibility significantly impacts the distribution of isotopes through the network [31]. Forward and backward reaction rates must be considered separately in the case of reversible reactions, like v 3 in the model considered here. Second, in the case of reactions with more than one substrate, the impact of KIEs on reaction rate may depend on the isotopic composition of each substrate. Therefore, one fluxomer must be defined for each combination of substrates isotopomers. Reaction v 3 was first decomposed into its forward (v 3 forw ) and backward (v 3 back ) components, each of them being then decomposed into fluxomers:
$$ {f}_{3,\ forw}^{B_{a,b,c}}={v}_3^{forw}.{\overline{B}}_{a,b,c} $$
(9)
$$ {f}_{3,\ back}^{C_a,{D}_{b,c}}={v}_3^{back}.{\overline{C}}_a.{\overline{D}}_{b,c} $$
(10)
and the mass balance around B a,c,b is:
$$ \frac{d{B}_{a,c,b}}{dt}={\alpha}_{v_2}^{A_{a,b,c}}.{f}_2^{A_{a,b,c}}+{\alpha}_{v_3}^{C_a}.{\alpha}_{v_3}^{D_{c,b}}.{f}_{3,\ back}^{C_a,{D}_{c,b}}-{\alpha}_{v_3}^{B_{a,c,b}}.{f}_{3,\ forw}^{B_{a,c,b}}-{\alpha}_{v_4}^{B_{a,c,b}}.{f}_4^{B_{a,c,b}} $$
(11)
Using the same formalism, the mass balances around the isotopomers of C, D and E are:
$$ \frac{d{C}_a}{dt}={\displaystyle \sum_{b,c}}\left({\alpha}_{v_3}^{B_{a,b,c}}.{f}_{3,\ forw}^{B_{a,b,c}}\right)-{\displaystyle \sum_{b,c}}\left({\alpha}_{v_3}^{C_a}.{\alpha}_{v_3}^{D_{b,c}}.{f}_{3,\ back}^{C_a,{D}_{b,c}}\right)-{\alpha}_{v_5}^{C_a}.{f}_5^{C_a} $$
(12)
$$ \frac{d{D}_{b,c}}{dt}=\sum_a\left({\alpha}_{v_3}^{B_{a,b,c}}.{f}_{3, forw}^{B_{a,b,c}}\right)-\sum_a\left({\alpha}_{v_3}^{C_a}.{\alpha}_{v_3}^{D_{b,c}}.{f}_{3, back}^{C_a,{D}_{b,c}}\right)-{\alpha}_{v_6}^{D_{b,c}}.{f}_6^{D_{b,c}} $$
(13)
$$ \frac{d{E}_{a,b,c}}{dt}={\alpha}_{v_4}^{B_{a,b,c}}.{f}_4^{B_{a,b,c}}-{\alpha}_{v_7}^{E_{a,b,c}}.{f}_7^{E_{a,b,c}} $$
(14)
The system of ordinary differential equations (ODEs) defined by Eqs. 8, 11, 12, 13, 14 can be transformed into matrix notation by defining a matrix U where rows correspond to isotopomers and columns correspond to fluxomers. This matrix contains the stoichiometric coefficients of each substrate(s) and product(s) isotopomer(s) for each fluxomer f r p (where p represents a particular (set of) substrate(s) isotopomer(s) consumed through the reaction r). A vector f is then defined that contains all the fluxomers (calculated from the kinetic rate laws of each reaction, the concentrations of reactants and effectors, and the relative abundances of substrate(s) isotopomers), and a vector a that contains the coefficients α r p for each fluxomer f r p . The isotopomer balances can be calculated by:
$$ \frac{dI}{dt}=U.\left(f(t)\circ a\right) $$
(15)
where I is the vector of isotopomer concentrations and is the element-wise product operator, i.e. (f(t) a) x  = f x (t). a x . The dynamics (and steady-states) of all the isotopomers can be simulated by solving this system of ODEs. Finally, fluxes and metabolite concentrations can be calculated by summing fluxomers and isotopomer concentrations, respectively. The numerical procedure and its implementation are summarized in Fig. 2.
Fig. 2

Diagram of the procedure developed to simulate the system-level impact of KIEs on metabolism. Blue boxes represent the input (definition of the metabolic system investigated and of its parameters), green and red boxes represent the steps implemented in R and FORTRAN, respectively, and orange box represents the output (simulation results). R is used to i) construct isotopic matrices, ii) create the FORTRAN library which contains the ODEs system, iii) initialize parameters, iv) solve ODEs and v) gather the results. Briefly, the FORTRAN library performs the following steps: i) computes metabolite concentrations (M) by summing isotopomer concentrations (I), function g, ii) calculates fluxes from metabolite concentrations (M) and kinetic parameters (p), function h, iii) decomposes fluxes (F) into fluxomers (f) using concentrations of isotopomers (I) and metabolites (M), function i, and iv) isotopomers derivatives are finally calculated from the isotopic matrix (U) and the fluxomers (f) and KIEs (a) vectors (Eq. 15)

Impact of KIEs on the operation of E. coli central metabolism in 13C-labeling experiments

We applied this framework to evaluate the impact of KIEs on the operation of the glycolytic and pentose phosphate pathways of the model bacterium Escherichia coli grown on 13C-labeled glucose. The kinetic model published by [30] was used as a scaffold to construct the isotopic model, with the carbon transition network taken from [6] (Fig. 3). KIEs measured on five enzymes were included (glucose-6-phosphate dehydrogenase, G6PDH; 6-phosphogluconate dehydrogenase, GND; ribulose-5-phosphate epimerase, RPE; fructose-1,6-bisphosphate aldolase, ALD; and pyruvate dehydrogenase, PDH), with the corresponding α r p coefficients listed in Table 1. Steady-states were simulated for glucose at natural abundance and six different glucose labelings: U-13C-glucose, a mixture containing 80 % of 1-13C- and 20 % of U-13C-glucose, an equimolar mixture of 12C- and U-13C-glucose, 2,3,4,5,6-13C-glucose, 1,2-13C-glucose and 3,4-13C-glucose. These label inputs are representative of those commonly used in 13C-ILEs [6, 3235].
Fig. 3

Central carbon metabolic network of Escherichia coli. Representation of the glucose uptake, glycolytic and pentose phosphate pathways of E. coli in SBGN format. Circles represent metabolites and rounded rectangles represent enzymes. Enzymes subjected to kinetic isotope effects are highlighted in orange. Note that the 17 reactions of dilution of intracellular pools due to growth are omitted from this diagram for clarity of the layout

For the metabolic state represented by the model, the relative changes of fluxes and metabolite concentrations caused by KIEs for each glucose input are shown in Fig. 4a and b, respectively. Impact on these variables is low (<2 %), with maximal changes observed when cells are grown on U-13C-glucose. Since in this situation all the metabolites are fully labeled, impact of KIEs on reaction rates is also maximal. For instance, assuming that KIEs are cumulative at the level of a single reaction [28], the reaction rate of the ribulose-5-phosphate epimerase (RPE) is reduced by 4.14 % when RB5P is fully labeled. However, the predicted change of flux (−1.7 %) is lower than that, which can be explained by the distribution of flux control over several reactions of the network. Moreover, the signs of the changes of fluxes and metabolite concentrations depend on the label input. This indicates that the impact of KIEs on the system cannot be intuitively inferred from their impact at the reaction level, even qualitatively. The impact of KIEs must be investigated at the system-level and not at the level of an isolated reaction or metabolic node.
Fig. 4

Impact of KIEs on the operation of E. coli central carbon metabolism. The impact of KIEs on the (steady-state) fluxes (a) and metabolite concentrations (b) of E. coli central carbon metabolism was simulated for glucose at natural abundance and six label inputs commonly used in 13C-labeling experiments. Impact of KIEs was defined as the relative difference between steady-states reached with and without KIEs, i.e. with alpha coefficients set to their experimental values (Table 1) or to 1, respectively

The predicted changes of metabolite concentrations are significantly lower than the precision commonly reached in metabolomics (circa 10 %) [18, 36], hence they cannot be detected with current methods. The same situation is observed for fluxes, with changes caused by KIEs slightly lower than the flux precision commonly obtained in 13C-metabolic flux analysis (13C-MFA) [5, 6, 12]. However, the predicted flux changes caused by KIEs are one order of magnitude higher than the flux precision estimated using parallel labeling experiments with different label inputs [37]. Therefore, fluxes obtained in high-resolution 13C-MFA studies might be biased, and KIEs should be considered during flux estimation and sensitivity analysis when such high degree of precision can be reached.

Impact of KIEs on isotopic patterns of central metabolites

Isotopic data collected in 13C-ILEs can be exploited quantitatively to infer information on the structure and the operation of metabolic systems. Since KIEs may impact isotopic data and ultimately jeopardize the validity of the biological interpretations, their impact must be assessed rigorously. This was performed for the various isotopic data that can be acquired with modern analytical platforms: isotopomer distributions [11, 38, 39], isotopologue distributions [7, 40] and molecular enrichments [40, 41]. The corresponding (steady-state) isotopic datasets were simulated in the absence or presence of KIEs, for three different label inputs: glucose at natural abundance, a mixture containing 80 % of 1-13C-glucose and 20 % of U-13C-glucose, and an equimolar mixture of 12C- and U-13C-glucose. The distributions of errors caused by KIEs are shown in Fig. 5 for each isotopic dataset and label input.
Fig. 5

Impact of KIEs on the distribution of isotopes in intracellular metabolites. The impact of KIEs on the different isotopic datasets of central metabolites (isotopologue abundances in panels a-c, isotopomer abundances in panels d-f and enrichments in panels g-i) was simulated for three label inputs: glucose at natural abundance, 80 % 1-13C-glucose + 20 % U-13C-glucose, and 50 % 12C-glucose + 50 % U-13C-glucose. Error is defined as the absolute difference between isotopic data simulated with and without KIEs, i.e. with alpha coefficients set to their experimental values (Table 1) or to 1, respectively

The sensitivity of isotopic data to KIEs strongly depends on the isotopic information considered and on the label input. As a general trend, the impact of KIEs is maximal for the equimolar mixture of 12C- and U-13C-glucose, and minimal for glucose at natural abundance. The predicted errors caused by KIEs are surprisingly low – below 0.001 – for virtually all metabolites and isotopic data. The only exception is pyruvate, with predicted errors up to 0.0045 for its isotopologues, 0.0047 for its isotopomers, and 0.0045 for its molecular enrichment. These errors originate exclusively from KIEs of pyruvate dehydrogenase (PDH). Here again, the system-level impact of KIEs on the isotopic distributions strongly differs from the impact that can be expected for isolated reactions. Moreover, impacts of individual KIEs do not add up at the system level, contrary to what was previously hypothesized [28].

This example illustrates how the framework developed here can be used to evaluate the sensitivity of each isotopic data to KIEs. The less reliable measurements with respect to KIEs can be identified and discarded from the datasets exploited in quantitative approaches such as 13C-MFA. In the situations investigated here, the biases caused by KIEs on the distribution of isotopes into the glycolytic and pentose phosphate pathway metabolic intermediates are significantly lower than the precision and accuracy obtained by MS (or even MS/MS) [40, 42] and NMR [10], which is around 1 %, and cannot be detected. Many other central metabolic enzymes are likely subject to KIEs, which may significantly increase their predicted impact on isotopic patterns. However, the present results support the assumption that KIEs can be neglected when studies focus on the glycolytic and pentose phosphate pathways and are based on isotopic information obtained from metabolic intermediates.

Isotopic data are robust to KIEs under a broad range of metabolic states

The above results indicate that isotopic data are robust to KIEs locally, i.e. near the given metabolic state investigated. However, metabolic systems are highly non-linear and the impact of KIEs might strongly differ depending on the metabolic state considered [28]. To grasp the global impact of KIEs on isotopic distributions, we first generated 10,000 sets of random enzyme levels for which we calculated the steady-states of the system with 80 % 1-13C- glucose + 20 % U-13C-glucose as label input. Although it is clear that these sets are not representative of those expressed in vivo, they are expected to result in different metabolic states. This was confirmed by analyzing the distribution of some systemic steady-state variables, e.g. the glucose uptake flux varied between 0.02 and 1.6 mmol/gDW/s, and the carbon channeled into glycolysis varied between 0 and 98 % of the glucose uptake flux (Fig. 6). For each metabolic state, errors caused by KIEs on the three isotopic datasets were calculated and are summarized in Fig. 7. Errors remain very low for the vast majority of isotopic data, with 99.7 % of absolute isotopomer errors below 0.002, 99.0 % of absolute isotopologue errors below 0.003, and 97 % of enrichment errors below 0.003. Here again errors strongly depend on the metabolite considered. For all isotopic datasets, the highest errors are related to pyruvate, consistently with the above results. Still, errors for this metabolite errors are minor in most cases (<0.003 for 89 % of its isotopomers and 77 % of its isotopologues). A more detailed analysis revealed that only the proportions of the unlabeled and fully labeled pyruvate isotopomers (and isotopologues) are significantly impacted by KIEs (Fig. 8), errors regarding other isotopomers (and isotopologues) remain very low (<0.002) under all the metabolic states. Errors related to other metabolites are minor (<0.003) for all the datasets, for instance the highest absolute error for glyceraldehyde-3-phosphate (GAP) isotopologues is 0.002. These results highlight a global robustness of the isotopic data measured on glycolytic and pentose phosphate pathway intermediates, and soften the conclusions of [28].
Fig. 6

Random sampling of enzyme levels results in a broad range of metabolic states. Distribution of the steady-state glucose uptake (a) and glycolytic (b) fluxes simulated from 10,000 sets of random enzyme levels

Fig. 7

Global impact of KIEs on isotopic patterns. Distributions of errors caused by KIEs on the isotopomer abundances (a), isotopologue abundances (b) and enrichments (c) of metabolic intermediates, simulated from 10,000 sets of random enzyme levels to cover a broad range of metabolic states. Error is defined as the absolute difference between isotopic data simulated with and without KIEs, i.e. with alpha coefficients set to their experimental values (Table 1) or to 1, respectively

Fig. 8

Global impact of KIEs on the isotopic content of pyruvate. The distributions of errors caused by KIEs on the (steady-state) abundances of pyruvate isotopomers (a) and isotopologues (b) were estimated from 10,000 sets of random enzyme levels. Error is defined as the absolute difference between isotopic data simulated with and without KIEs, i.e. with alpha coefficients set to their experimental values (Table 1) or to 1, respectively

Reversibility is a key determinant of the robustness of isotopic patterns

In a linear pathway with an irreversible step (i.e. not subject to feedback inhibition by its product(s)), reactions downstream the irreversible step do not exert any flux control [43]. Reversibility therefore participates in the robustness of the metabolic operation to KIEs by contributing to the distribution of (flux and concentration) control via feedback regulation. In ILEs, another consequence of reversibility is the bidirectional exchange of isotopes that occurs between substrates and products of reversible reactions. To test if this exchange also plays a role in the robustness of isotope distribution to KIEs, a model of the same network was generated without explicitly considering isotope exchange in the isotopomer balances, i.e. without decoupling forward and backward reaction rates when constructing the equation system. It is important to mention that all the systemic properties that emerge from metabolic regulation (in particular the distributed control) are identical in both models since the rate laws remain unchanged. With the two models, the impact of KIEs on isotopologue abundances was simulated with and without isotope exchange (Fig. 9). Errors caused by KIEs were significantly higher for all metabolites when exchange was not explicitly considered, with a 10-fold increase of the mean of absolute errors (0.0014 vs 0.00015). Moreover, errors increased for all metabolites. For instance, while errors on fructose-6-phosphate (F6P) and dihydroxyacetone phosphate (DHAP) isotopologues are negligible with exchange (<0.0002 for both metabolites), they increase up to 0.006 for F6P and 0.008 for DHAP without exchange. Hence, reversibility appears as a key determinant of the robustness of isotopic data to KIEs, both by contributing to the distribution of control across the network and by enabling bidirectional exchange of isotopes between metabolites.
Fig. 9

Impact of bidirectional isotope exchanges on the robustness of isotopic data to KIEs. The impact of KIEs on the isotopologue abundances of central metabolites was simulated for 80 % 1-13C-glucose + 20 % U-13C-glucose as label input, with (red squares) or without (blue squares) considering isotope exchange caused by reaction reversibility. Error is defined as the absolute difference between isotopic data simulated with and without KIEs, i.e. with alpha coefficients set to their experimental values (Table 1) or to 1, respectively

This is consistent with the 13C-depletion observed in amino acids [44] since they are produced by less reversible biosynthetic pathways and are therefore expected to be more sensitive to KIEs. Conversely, no major isotopic fractionation was detected on central metabolites in a recent study aiming to produce standard samples that contain metabolites with controlled and predictable isotopic contents [40]. Our simulations support these conclusions and strengthen the reliability of the proposed strategy. These results stress the necessity to take into account reversibility, or at least to evaluate the potential consequences of neglecting this important property of metabolic systems, when integrating isotopic data into quantitative models.

Conclusion

In this work we introduce a framework that allows comprehensive and rigorous investigations on the impact of KIEs in isotopic studies of metabolism. This framework integrates KIEs into kinetic and isotopic models of metabolism, thereby accounting for their effects on metabolite concentrations, isotopic patterns, and metabolic fluxes on a system-wide basis.

As a case study, this framework was applied to assess the impact of KIEs on i) the operation of the central metabolic network of Escherichia coli and ii) the distribution of isotopes into metabolic intermediates, in the context of 13C-ILEs under metabolic steady state conditions. Simulations showed that the impact of KIEs is lower than expected from measurements obtained on isolated enzymes. Robustness of the metabolic operation – and thus also of the distribution of isotopes – to KIEs partly originates from the distribution of concentration and flux control over several steps of the network. Bidirectional isotope exchange due to reversibility is also a major determinant of the robustness of the isotopic patterns. This robustness was observed for virtually all the metabolic intermediates, for all the label inputs tested, and under a broad range of metabolic states. It is therefore unlikely that KIEs jeopardize the biological insights obtained in 13C-ILEs, at least for the metabolic network investigated here. The low impact of KIEs on central metabolic intermediates also confirms the interest of quantifying the labeling directly in these intermediates rather than in metabolic end products (such as proteinogenic amino acids). It is important to note that the impact of KIEs may be significant in other situations (in terms of isotopic tracers, metabolic pathways or analytical platforms) and should be evaluated in the specific context of each study.

These findings soften the suggestions of previous studies that 13C- KIEs would have a strong effect on isotopic distributions [28] and stresses the necessity of considering reversibility in isotopic studies. It now appears evident that the impact of KIEs on metabolic systems must be investigated at the system level. Unfortunately, KIEs are still unknown for many enzymes, and in most cases they are measured only for some isotopomers. It seems therefore important to dedicate more efforts to in vitro characterization of KIEs. Future knowledge can be readily integrated into the model developed here to obtain a more accurate picture of their impact on the system.

The proposed modeling framework is generic and is applicable for other metabolic systems, for different isotopic tracers (e.g. 2H, 18O or 15N), or for other systemic variables. It may therefore facilitate accurate interpretation of isotopic data collected in ILEs and increase the reliability of the biological insights inferred from these data. We are also considering the application of this framework to better exploit the rich isotopic information collected in ILEs. In particular, it may allow a more accurate estimation of in vivo kinetic parameters of enzymes by integrating isotopic and metabolomic measurements obtained under metabolic and/or isotopic non-stationary states [45]. This is expected to improve the predictive and explicative capabilities of kinetic models, and thereby their applicability for in silico design of industrially competitive cell factories [46].

Availability of supporting data

The data sets supporting the results of this article are included within the article and its additional files.

Abbreviations

13C-MFA: 

13C-metabolic flux analysis

ALD: 

Fructose-1,6-bisphosphate aldolase

DHAP: 

Dihydroxyacetone phosphate

F6P: 

Fructose-6-phoshate

G6PDH: 

Glucose-6-phosphate dehydrogenase

GAP: 

Glyceraldehyde-3-phosphate

GND: 

6-phosphogluconate dehydrogenase

ILE: 

Isotope labeling experiment

KIE: 

Kinetic isotope effect

MS: 

Mass spectrometry

NMR: 

Nuclear magnetic resonance

ODEs: 

Ordinary differential equations

PDH: 

Pyruvate dehydrogenase

RPE: 

Ribulose-5-phosphate epimerase

Declarations

Acknowledgments

We thank MetaToul (Metabolomics & Fluxomics facilities, Toulouse, France, www.metatoul.fr), which is part of the national infrastructure MetaboHUB-ANR-11-INBS-0010 (The French National Infrastructure for Metabolomics and Fluxomics, www.metabohub.fr), for providing us with free access to its computational resources. We thank Matthieu Guionnet for technical assistance and Serguei Sokol for insightful comments on the manuscript. PMi received the support of the INRA (Program CJS) and of the EU in the framework of the Marie-Curie FP7 COFUND People Program, through the award of an AgreenSkills’ fellowship (under grant agreement n° 267196). PMe was supported by grants from the EU FP7 (KBBE grant 289434 – BioPreDyn), the UK’s BBSRC (BB/K019783/1, BB/J019259/1), and the NIH-NIGMS (GM080219). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
MCISB, Manchester Institute of Biotechnology, University of Manchester
(2)
School of Computer Science, University of Manchester
(3)
Université de Toulouse; INSA, UPS, INP; LISBP
(4)
INRA, UMR792, Ingénierie des Systèmes Biologiques et des Procédés
(5)
CNRS, UMR5504
(6)
Center for Quantitative Medicine and Department of Cell Biology, UConn Health

References

  1. Feng X, Page L, Rubens J, Chircus L, Colletti P, Pakrasi HB, et al. Bridging the gap between fluxomics and industrial biotechnology. J Biomed Biotechnol. 2010;2010:460717. doi:10.1155/2010/460717.PubMed CentralPubMedGoogle Scholar
  2. You L, Zhang B, Tang YJ. Application of stable isotope-assisted metabolomics for cell metabolism studies. Metabolites. 2014;4(2):142–65. doi:10.3390/metabo4020142.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Klein S, Heinzle E. Isotope labeling experiments in metabolomics and fluxomics. Wiley Interdiscip Rev Syst Biol Med. 2012;4(3):261–72. doi:10.1002/wsbm.1167.View ArticlePubMedGoogle Scholar
  4. Chokkathukalam A, Kim DH, Barrett MP, Breitling R, Creek DJ. Stable isotope-labeling studies in metabolomics: new insights into structure and dynamics of metabolic networks. Bioanalysis. 2014;6(4):511–24. doi:10.4155/bio.13.348.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Millard P, Sokol S, Letisse F, Portais JC. IsoDesign: A software for optimizing the design of 13C-metabolic flux analysis experiments. Biotechnol Bioeng. 2014;111(1):202–8. doi:10.1002/bit.24997.View ArticlePubMedGoogle Scholar
  6. Millard P, Massou S, Wittmann C, Portais JC, Letisse F. Sampling of intracellular metabolites for stationary and non-stationary 13C metabolic flux analysis in Escherichia coli. Anal Biochem. 2014;465C:38–49. doi:10.1016/j.ab.2014.07.026.View ArticleGoogle Scholar
  7. Wittmann C. Fluxome analysis using GC-MS. Microb Cell Fact. 2007;6:6. doi:10.1186/1475-2859-6-6.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Bolten CJ, Kiefer P, Letisse F, Portais JC, Wittmann C. Sampling for metabolome analysis of microorganisms. Anal Chem. 2007;79(10):3843–9. doi:10.1021/ac0623888.View ArticlePubMedGoogle Scholar
  9. Kiefer P, Nicolas C, Letisse F, Portais JC. Determination of carbon labeling distribution of intracellular metabolites from single fragment ions by ion chromatography tandem mass spectrometry. Anal Biochem. 2007;360(2):182–8. doi:10.1016/j.ab.2006.06.032.View ArticlePubMedGoogle Scholar
  10. Giraudeau P, Massou S, Robin Y, Cahoreau E, Portais JC, Akoka S. Ultrafast quantitative 2D NMR: an efficient tool for the measurement of specific isotopic enrichments in complex biological mixtures. Anal Chem. 2011;83(8):3112–9. doi:10.1021/ac200007p.View ArticlePubMedGoogle Scholar
  11. Massou S, Nicolas C, Letisse F, Portais JC. NMR-based fluxomics: quantitative 2D NMR methods for isotopomers analysis. Phytochemistry. 2007;68(16–18):2330–40. doi:10.1016/j.phytochem.2007.03.011.View ArticlePubMedGoogle Scholar
  12. Ruhl M, Rupp B, Noh K, Wiechert W, Sauer U, Zamboni N. Collisional fragmentation of central carbon metabolites in LC-MS/MS increases precision of 13C metabolic flux analysis. Biotechnol Bioeng. 2012;109(3):763–71. doi:10.1002/bit.24344.View ArticlePubMedGoogle Scholar
  13. Peyraud R, Kiefer P, Christen P, Massou S, Portais JC, Vorholt JA. Demonstration of the ethylmalonyl-CoA pathway by using 13C metabolomics. Proc Natl Acad Sci U S A. 2009;106(12):4846–51. doi:10.1073/pnas.0810932106.PubMed CentralView ArticlePubMedGoogle Scholar
  14. Huang X, Chen YJ, Cho K, Nikolskiy I, Crawford PA, Patti GJ. X13CMS: global tracking of isotopic labels in untargeted metabolomics. Anal Chem. 2014;86(3):1632–9. doi:10.1021/ac403384n.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Link H, Kochanowski K, Sauer U. Systematic identification of allosteric protein-metabolite interactions that control enzyme activity in vivo. Nat Biotechnol. 2013;31(4):357–61. doi:10.1038/nbt.2489.View ArticlePubMedGoogle Scholar
  16. Heux S, Poinot J, Massou S, Sokol S, Portais JC. A novel platform for automated high-throughput fluxome profiling of metabolic variants. Metab Eng. 2014;25:8–19. doi:10.1016/j.ymben.2014.06.001.View ArticlePubMedGoogle Scholar
  17. Fischer E, Sauer U. Metabolic flux profiling of Escherichia coli mutants in central carbon metabolism using GC-MS. Eur J Biochem. 2003;270(5):880–91. doi:10.1046/j.1432-1033.2003.03448.x.View ArticlePubMedGoogle Scholar
  18. Revelles O, Millard P, Nougayrede JP, Dobrindt U, Oswald E, Letisse F, et al. The Carbon storage regulator (Csr) system exerts a nutrient-specific control over central metabolism in Escherichia coli strain Nissle 1917. PLoS One. 2013;8(6):e66386. doi:10.1371/journal.pone.0066386.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Fan J, Ye J, Kamphorst JJ, Shlomi T, Thompson CB, Rabinowitz JD. Quantitative flux analysis reveals folate-dependent NADPH production. Nature. 2014;510(7504):298–302. doi:10.1038/nature13236.PubMed CentralView ArticlePubMedGoogle Scholar
  20. Cleland WW. The use of isotope effects to determine enzyme mechanisms. Arch Biochem Biophys. 2005;433(1):2–12. doi:10.1016/j.abb.2004.08.027.View ArticlePubMedGoogle Scholar
  21. Guy RD, Fogel ML, Berry JA. Photosynthetic fractionation of the stable isotopes of oxygen and carbon. Plant Physiol. 1993;101(1):37–47.PubMed CentralPubMedGoogle Scholar
  22. Kacser H, Burns JA. The control of flux. Symp Soc Exp Biol. 1973;27:65–104.PubMedGoogle Scholar
  23. Heinrich R, Rapoport TA. A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. Eur J Biochem. 1974;42(1):89–95.View ArticlePubMedGoogle Scholar
  24. Schaaff I, Heinisch J, Zimmermann FK. Overproduction of glycolytic enzymes in yeast. Yeast. 1989;5(4):285–90. doi:10.1002/yea.320050408.View ArticlePubMedGoogle Scholar
  25. Ruyter GJ, Postma PW, van Dam K. Control of glucose metabolism by enzyme IIGlc of the phosphoenolpyruvate-dependent phosphotransferase system in Escherichia coli. J Bacteriol. 1991;173(19):6184–91.PubMed CentralPubMedGoogle Scholar
  26. Fell DA, Thomas S. Physiological control of metabolic flux: the requirement for multisite modulation. Biochem J. 1995;311(1):35–9.PubMed CentralView ArticlePubMedGoogle Scholar
  27. Niederberger P, Prasad R, Miozzari G, Kacser H. A strategy for increasing an in vivo flux by genetic manipulations. The tryptophan system of yeast. Biochem J. 1992;287(Pt 2):473–9.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Wasylenko TM, Stephanopoulos G. Kinetic isotope effects significantly influence intracellular metabolite 13C labeling patterns and flux determination. Biotechnol J. 2013;8(9):1080–9. doi:10.1002/biot.201200276.PubMed CentralView ArticlePubMedGoogle Scholar
  29. Srour O, Young JD, Eldar YC. Fluxomers: a new approach for 13C metabolic flux analysis. BMC Syst Biol. 2011;5(1):129. doi:10.1186/1752-0509-5-129.PubMed CentralView ArticlePubMedGoogle Scholar
  30. Chassagnole C, Noisommit-Rizzi N, Schmid JW, Mauch K, Reuss M. Dynamic modeling of the central carbon metabolism of Escherichia coli. Biotechnol Bioeng. 2002;79(1):53–73.View ArticlePubMedGoogle Scholar
  31. Wiechert W, Mollney M, Petersen S, de Graaf AA. A universal framework for 13C metabolic flux analysis. Metab Eng. 2001;3(3):265–83. doi:10.1006/mben.2001.0188.View ArticlePubMedGoogle Scholar
  32. van Rijsewijk BR H, Nanchen A, Nallet S, Kleijn RJ, Sauer U. Large-scale 13C-flux analysis reveals distinct transcriptional control of respiratory and fermentative metabolism in Escherichia coli. Mol Syst Biol. 2011;7:477. doi:10.1038/msb.2011.9.View ArticleGoogle Scholar
  33. Wu L, Mashego MR, van Dam JC, Proell AM, Vinke JL, Ras C, et al. Quantitative analysis of the microbial metabolome by isotope dilution mass spectrometry using uniformly 13C-labeled cell extracts as internal standards. Anal Biochem. 2005;336(2):164–71. doi:10.1016/j.ab.2004.09.001.View ArticlePubMedGoogle Scholar
  34. Nanchen A, Fuhrer T, Sauer U. Determination of metabolic flux ratios from 13C-experiments and gas chromatography–mass spectrometry data: protocol and principles. Methods Mol Biol. 2007;358:177–97. doi:10.1007/978-1-59745-244-0:177.View ArticlePubMedGoogle Scholar
  35. Crown SB, Ahn WS, Antoniewicz MR. Rational design of 13C-labeling experiments for metabolic flux analysis in mammalian cells. BMC Syst Biol. 2012;6(1):43. doi:10.1186/1752-0509-6-43.PubMed CentralView ArticlePubMedGoogle Scholar
  36. Taymaz-Nikerel H, de Mey M, Ras C, ten Pierick A, Seifar RM, van Dam JC, et al. Development and application of a differential method for reliable metabolome analysis in Escherichia coli. Anal Biochem. 2009;386(1):9–19. doi:10.1016/j.ab.2008.11.018.View ArticlePubMedGoogle Scholar
  37. Au J, Choi J, Jones SW, Venkataramanan KP, Antoniewicz MR. Parallel labeling experiments validate Clostridium acetobutylicum metabolic network model for 13C metabolic flux analysis. Metab Eng. 2014;26C:23–33. doi:10.1016/j.ymben.2014.08.002.View ArticleGoogle Scholar
  38. Giraudeau P, Cahoreau E, Massou S, Pathan M, Portais JC, Akoka S. UFJCOSY: a fast 3D NMR method for measuring isotopic enrichments in complex samples. Chemphyschem. 2012;13(13):3098–101. doi:10.1002/cphc.201200255.View ArticlePubMedGoogle Scholar
  39. Cahoreau E, Peyriga L, Hubert J, Bringaud F, Massou S, Portais JC. Isotopic profiling of 13C-labeled biological samples by two-dimensional heteronuclear J-resolved nuclear magnetic resonance spectroscopy. Anal Biochem. 2012;427(2):158–63. doi:10.1016/j.ab.2012.05.021.View ArticlePubMedGoogle Scholar
  40. Millard P, Massou S, Portais JC, Letisse F. Isotopic studies of metabolic systems by mass spectrometry: using Pascal's triangle to produce biological standards with fully controlled labeling patterns. Anal Chem. 2014;86(20):10288–95. doi:10.1021/ac502490g.View ArticlePubMedGoogle Scholar
  41. Heinzle E, Yuan Y, Kumar S, Wittmann C, Gehre M, Richnow HH, et al. Analysis of 13C labeling enrichment in microbial culture applying metabolic tracer experiments using gas chromatography-combustion-isotope ratio mass spectrometry. Anal Biochem. 2008;380(2):202–10. doi:10.1016/j.ab.2008.05.039.View ArticlePubMedGoogle Scholar
  42. Guerrasio R, Haberhauer-Troyer C, Steiger M, Sauer M, Mattanovich D, Koellensperger G, et al. Measurement uncertainty of isotopologue fractions in fluxomics determined via mass spectrometry. Anal Bioanal Chem. 2013;405(15):5133–46. doi:10.1007/s00216-013-6910-5.View ArticlePubMedGoogle Scholar
  43. Cornish-Bowden A, Cárdenas ML. Irreversible reactions in metabolic simulations: how reversible is irreversible? In: Hofmeyr JH, Rohwer J, Snoep JL, editors. Animating the cellular map. Stellenbosch University Press; Stellenbosch 2000. p. 65–71.Google Scholar
  44. Yuan Y, Yang TH, Heinzle E. 13C metabolic flux analysis for larger scale cultivation using gas chromatography-combustion-isotope ratio mass spectrometry. Metab Eng. 2010;12(4):392–400. doi:10.1016/j.ymben.2010.02.001.View ArticlePubMedGoogle Scholar
  45. Wahl SA, Noh K, Wiechert W. 13C labeling experiments at metabolic nonstationary conditions: an exploratory study. BMC Bioinformatics. 2008;9:152. doi:10.1186/1471-2105-9-152.PubMed CentralView ArticlePubMedGoogle Scholar
  46. Almquist J, Cvijovic M, Hatzimanikatis V, Nielsen J, Jirstrand M. Kinetic models in industrial biotechnology - Improving cell factory performance. Metab Eng. 2014;24:38–60. doi:10.1016/j.ymben.2014.03.007.View ArticlePubMedGoogle Scholar
  47. Le Novere N, Hucka M, Mi H, Moodie S, Schreiber F, Sorokin A, et al. The Systems Biology Graphical Notation. Nat Biotechnol. 2009;27(8):735–41. doi:10.1038/nbt.1558.View ArticlePubMedGoogle Scholar
  48. Rendina AR, Hermes JD, Cleland WW. Use of multiple isotope effects to study the mechanism of 6-phosphogluconate dehydrogenase. Biochemistry. 1984;23(25):6257–62.View ArticlePubMedGoogle Scholar
  49. Hermes JD, Roeske CA, O'Leary MH, Cleland WW. Use of multiple isotope effects to determine enzyme mechanisms and intrinsic isotope effects. Malic enzyme and glucose-6-phosphate dehydrogenase. Biochemistry. 1982;21(20):5106–14.View ArticlePubMedGoogle Scholar
  50. Gleixner G, Schmidt HL. Carbon isotope effects on the fructose-1,6-bisphosphate aldolase reaction, origin for non-statistical 13C distributions in carbohydrates. J Biol Chem. 1997;272(9):5382–7.View ArticlePubMedGoogle Scholar
  51. Lee LV, Vu MV, Cleland WW. 13C and deuterium isotope effects suggest an aldol cleavage mechanism for L-ribulose-5-phosphate 4-epimerase. Biochemistry. 2000;39(16):4808–20.View ArticlePubMedGoogle Scholar
  52. Melzer E, Schmidt HL. Carbon isotope effects on the pyruvate dehydrogenase reaction and their importance for relative carbon-13 depletion in lipids. J Biol Chem. 1987;262(17):8159–64.PubMedGoogle Scholar

Copyright

© Millard et al. 2015